NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating Officer. Ms. Webb Dray, an accomplished operations and supply chain executive with over 15 years of experience, has been an integral part of LifeMD's growth, most recently serving as Senior Vice Pre...
There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.
LifeMD is a fast-growing, profitable telehealth company with strong partnerships, a robust tech stack and a valuable SaaS asset. The Novo Nordisk/Hims fallout is bullish, not bearish, for LifeMD. Novo Nordisk and Eli Lilly are unlikely to break a partnership with LifeMD. Q1 2025 results showed an excellent inflection into profitability, but guidance was conservative and gross margins declined d...
LifeMD has evolved through multiple rebrandings, now offering 24/7 virtual primary and urgent care access to patients. The company operates RexMD, a men's telehealth platform, serving around 500,000 customers with specialty health products. LifeMD owns a majority stake in WorkSimpli, which delivers high-margin, recurring revenue through digital workplace services like PDFSimpli and ResumeBuild.
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: BTIG Obesity Health Forum, June 18. Management will participate in a virtual panel discussion titled “Direct to Consumer vs.
LifeMD is experiencing a major growth inflection, with record Q1 revenue, first-ever GAAP profitability, and strong subscriber and margin gains. Multiple growth drivers - including GLP-1 programs, Medicare expansion, AI automation, and a women's health acquisition - support a robust multi-year growth outlook. Valuation is high on earnings metrics but discounted on sales multiples. Significant u...
Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.